What is Parkinson’s Disease?
Parkinson’s disease is neurological disorder that deteriorates the production of dopamine within the brain; dopamine serves as a neurotransmitter that transfers signals between brain cells. Parkinson’s causes the brain cells responsible for creating dopamine to die; this process often results in physical impairment and displays symptoms such as rigid muscles and spasms, tremors, loss of balance, cognitive failure, and even dementia.
Approximately 1 million people in the U.S. valiantly try to lead regular lives with Parkinson’s disease. And even though there are various prescriptions to help ease constricting symptoms, many can cause other dangerous health conditions. With no cure in the foreseeable future, several patients risk the dangers of neurosurgery to regulate more difficult issues.
Research has uncovered a link between cannabidiol (CBD), the endocannabinoid system (ECS) and Parkinson’s; indications show CBD interactions with CB1 and CB2 receptors of the ECS causes a release of dopamine which manages various cognitive functions.
Clinical examinations report patients with Parkinson’s experienced dramatic improvements with tremors, sleep, pain, motor ability, and other common symptoms. Patients described a better quality of life and general well-being after using CBD for Parkinson's for just one week.
Other trials conclude CBD helping patients by reducing probability of sleep disorders and decreasing psychotic symptoms with prolonged use.
Furthermore, scientists have discovered how the loss of dopamine cells possibly affects the endocannabinoid system; there is a high accumulation of cannabinoid receptors inside the basal ganglia - the group of neurons that manages body movement. When Parkinson’s disease affects the basal ganglia, the receptors of the ECS can directly release it beneficial effects.